What is ARYA Sciences Acquisition Corp V (ARYE) stock price today?

ARYA Sciences Acquisition Corp V (ARYE) is currently trading at $10.36, down 0.19% today.

What is ARYE P/E ratio?

ARYA Sciences Acquisition Corp V's P/E ratio is 11.77. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is ARYE return on equity (ROE)?

ARYA Sciences Acquisition Corp V's return on equity (ROE) is 2.27%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is ARYA Sciences Acquisition Corp V's market cap?

ARYA Sciences Acquisition Corp V has a market capitalization of $198.77M.

NASDAQ · Shell Companies

ARYA Sciences Acquisition Corp V (ARYE) Stock

$10.36 -0.19% NASDAQ: ARYE Financial Services

ARYA Sciences Acquisition Corp V currently has no substantial business activities. This company, established in 2021 and based in New York, New York, was formed with the specific aim of completing a business combination, such as a merger, acquisition of shares or assets, or a reorganization, with one or more entities operating within the healthcare or related sectors.

Valuation

Metric	Value
Price	$10.36
Market Cap	$198.77M
P/E Ratio	11.77
P/B Ratio	0.26
P/S Ratio	0.00
EPS (TTM)	$0.88
52-Week High	$10.50
52-Week Low	$9.70
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	2.27%
ROA	2.16%
ROCE	-0.57%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.00
Current Ratio	0.19

Annual Financials (USD)

Metric	2021	2022
Revenue	$0	$0
Operating Profit	$-3.0M	$-1.0M
Net Profit	$-3.0M	$3.0M
EPS	$-0.15	$0.88
Op Margin	—	—

Balance Sheet (USD)

Metric	2021	2022
Total Assets	$151.0M	$152.0M
Total Liabilities	$8.0M	$5.0M
Cash	$1.0M	$0
Borrowings	$0	$0

Cash Flow (USD)

Metric	2021	2022
Operating Cash Flow	$-1.0M	$0
Investing Cash Flow	$-149.0M	$0
Financing Cash Flow	$151.0M	$0
Net Cash Flow	$1.0M	$0
Free Cash Flow	$-1.0M	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.03
EV / EBITDA	-231.75
FCF Yield	-0.20%
Quick Ratio	0.19
Interest Coverage	0.00
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ALPAAlpha Healthcare Acquisition Corp. III	$9.80	+0.10%	-1.78	$193.74M	0.00%
APMIAxonPrime Infrastructure Acquisition Corporation	$10.33	+0.10%	—	$193.69M	0.00%
BIOSBioPlus Acquisition Corp.	$10.80	-0.05%	1255.23	$209.07M	0.00%
FACTFACT II Acquisition Corp	$10.64	+0.05%	48.56	$258.78M	0.00%
GLTAGalata Acquisition Corp.	$10.73	-27.50%	120.70	$192.81M	0.00%

About ARYA Sciences Acquisition Corp V

ARYA Sciences Acquisition Corp V is headquartered in US.

ARYA Sciences Acquisition Corp V (ARYE) stock trades at $10.36 with a market capitalization of $198.77M. The stock is valued at a price-to-earnings (P/E) ratio of 11.77, price-to-book of 0.26, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $9.70 and $10.50, and currently trades 1.3% below its 52-week high.

On profitability, ARYA Sciences Acquisition Corp V generates a return on equity (ROE) of 2.27%, return on capital employed of -0.57%, an operating margin of 0.00%, a net profit margin of 0.00%.